Ghost Tree Capital »

Phathom Pharmaceuticals shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.1M 395k 10.37
2023-06-30 $2.2M 154k 14.32

More positions owned by Ghost Tree Capital

Moonlake Immunotherapeutics Class A Ord (MLTX)
Sarepta Therapeutics (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
Akero Therapeutics (AKRO)
Krystal Biotech (KRYS)
Madrigal Pharmaceuticals (MDGL)
Tg Therapeutics (TGTX)
Immunovant (IMVT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Axsome Therapeutics (AXSM)
Alpine Immune Sciences (ALPN)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Tarsus Pharmaceuticals (TARS)
Apellis Pharmaceuticals Call Option (APLS)

View all positions for Ghost Tree Capital

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
NEA Management Company
Vanguard Group
Avidity Partners Management
Gilder, Gagnon, Howe & Co
683 Capital Management
Decheng Capital
Newtyn Management
Jacobs Levy Equity Management
Kennedy Capital Management
Jennifer Ranahan
Propel Bio Management
Checkpoint Capital

View all funds holding Phathom Pharmaceuticals